Press release
mRNA Therapeutics Industry Outlook 2025-2029: Market Set to Cross $41.08 Billion Milestone
mRNA Therapeutics
How Large Will the mRNA Therapeutics Market Size By 2025?
In the past few years, the market size of mRNA therapeutics has been progressively expanding. The prediction is that it will rise from $34.76 billion in 2024 to approximately $35.9 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 3.3%. The growth during the historic period can be credited to factors such as increased financial backing for the development of effective pharmaceuticals and vaccines, the broadening of government programs aimed at promoting RNA-based medicines, heightened recognition of rare genetic diseases and an upsurge in the number of clinical trials.
How Big Is the mRNA Therapeutics Market Size Expected to Grow by 2029?
Expectations are high for a stable expansion of the mRNA therapeutics market size in the coming years. By 2029, the market is projected to reach a value of $41.08 billion, with a compound annual growth rate (CAGR) of 3.4%. This anticipated growth during this period can be tied to factors such as the rising incidence of infectious diseases, an increase in patients frequenting hospitals and clinics, the broadening uses of mRNA therapeutics, heightened demand for personalized and precision treatments, conducive regulatory conditions, and fast-tracked approval processes. Predicted trends for this period entail developments in mRNA delivery technology, swift progression and acceptance of mRNA vaccines, the introduction of self-amplifying mRNA (saRNA) platforms, the capability of scaling and flexibility in mRNA production, and the creation of unique mRNA modifications.
View the full report here:
https://www.thebusinessresearchcompany.com/report/mrna-therapeutics-global-market-report
Which Key Market Drivers Powering mRNA Therapeutics Market Expansion and Growth?
The rise in long-term and communicable diseases is predicted to stimulate the expansion of the mRNA therapeutics market. Persistent and transferrable diseases, including tuberculosis, HIV/AIDS, and hepatitis, are conditions that last for a substantial length of time and can be spread from person to person. Factors such as increased global mobility and inadequate healthcare systems are contributing to the growing prevalence of these diseases, as they both ease their transmission and complicate their effective controls. mRNA therapeutics are beneficial in addressing these diseases by quickly aiding the body to generate proteins that enhance immune responses, thus accelerating the creation of vaccines and treatments. To exemplify, GOV.UK, a UK-based government website, reported in October 2023 that the number of people diagnosed with HIV and receiving treatment in England reached 94,397 in 2022, representing a 3% rise from the 91,368 individuals in 2021. Consequently, the escalating prevalence of persistent and transmittable diseases is driving the expansion of the mRNA therapeutics market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17205&type=smp
What Are the Key Trends Driving mRNA Therapeutics Market Growth?
Key players in the mRNA therapeutics market are prioritizing the creation of innovative solutions, such as mRNA-based booster vaccines, to increase immunity against constantly changing viral variations. An mRNA-based booster vaccine uses messenger RNA technology to strengthen and extend immunity against a specific pathogen, usually following an initial series of vaccinations. In June 2023, for example, Gennova Biopharmaceuticals Ltd., a pharmaceutical company based in India, introduced India's first locally produced mRNA-based booster vaccine specifically for the Omicron variant, named GEMCOVAC-OM. This vaccine is intended to stimulate the appropriate immune response against the Omicron version of SARS-CoV-2. GEMCOVAC-OM is stable at room temperature, doesn't need an ultra-cold chain infrastructure, and can be administered using a needle-free device system, which makes it suitable for widespread use in India's remote areas. Clinical trials have shown that this vaccine triggers significantly greater immune responses compared to other vaccines, highlighting the importance of variant-specific vaccines in achieving the required immune responses.
What Are the Emerging Segments in the mRNA Therapeutics Market?
The mrna therapeutics market covered in this report is segmented -
1) By Product: Vaccines, Drugs
2) By Application: Infectious Diseases, Oncology, Rare Genetic Diseases, Respiratory Diseases, Other Applications
3) By End Use: Hospitals And Clinics, Research Organizations, Other End Uses
Subsegments:
1) By Vaccines: Infectious Disease Vaccines, Cancer Vaccines, Other Therapeutic Vaccines
2) By Drugs: Oncology Drugs, Cardiovascular Drugs, Autoimmune Disease Drugs, Other mRNA-Based Drugs
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=17205&type=smp
Who Are the Global Leaders in the mRNA Therapeutics Market?
Major companies operating in the mRNA therapeutics market are Pfizer Inc., Novartis AG, Sanofi AG, AstraZeneca plc, GlaxoSmithKline plc, Hoffmann-La Roche AG, Moderna Therapeutics Inc, BioNTech SE, Vertex Pharmaceuticals Incorporated, Catalent Inc, Alnylam Pharmaceuticals Inc, Sarepta Therapeutics Inc, Arcturus Therapeutics Holdings Inc, CureVac N.V, Ethris GMBH, eTheRNA immunotherapies NV, In-Cell-Art S.A.S., Nutcracker Therapeutics Inc, SCM LifeScience Co Ltd, Suzhou Abogen Biosciences Co Ltd, Tiba Biotech LLC, CSPC Pharmaceutical Group, CRISPR Therapeutics AG
Which are the Top Profitable Regional Markets for the mRNA Therapeutics Industry?
North America was the largest region in the mRNA therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mRNA therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17205
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release mRNA Therapeutics Industry Outlook 2025-2029: Market Set to Cross $41.08 Billion Milestone here
News-ID: 4183317 • Views: …
More Releases from The Business Research Company
Tacrolimus Market Poised to Hit $8.68 Billion by 2029 with Accelerating Growth T …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Tacrolimus Market Size Growth Forecast: What to Expect by 2025?
The market size of tacrolimus has seen robust growth over the past few years. It is projected to increase from $6.59 billion in 2024 to $6.97 billion in 2025, with a compound annual growth rate (CAGR) of 5.7%. The…
Future of the Research-Grade Proteins Market: Strategic Analysis and Forecast to …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Research-Grade Proteins Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
Recent years have seen a significant expansion in the market size for research-grade proteins. The market, which was valued at $1.11 billion in 2024, is projected to rise to $1.33 billion in 2025, marking a…
Key Trends Influencing the Growth of the Peptide Based Metabolic Disorders Thera …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Peptide Based Metabolic Disorders Therapeutics Market Through 2025?
The market size for therapeutics centered around peptide-based metabolic disorders has visibly expanded in the last few years. It is projected to escalate from $29.89 billion in 2024 to $34.1 billion in 2025, reflecting…
Oral Transmucosal Drugs: Core Growth Enabler in the Parkinson's Disease Driving …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Oral Transmucosal Drugs Industry Market Size Be by 2025?
Significant growth has been observed in recent years in the market for oral transmucosal drugs. The market, valued at $39.7 billion in 2024, is predicted to expand to $43.21 billion in 2025, with a compound annual growth…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
